Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In Vivo
Source abstract
Abstract
Abstract The efficacy of conventional antibiotics therapeutics has declined rapidly due to the emerged antibiotic resistance. There is an urgent need to develop novel approaches to address the problem of antibiotic shortage, particularly for Gram‐negative bacteria. Herein, a biomimetic nanodelivery system is proposed to enhance the bacterial targeting and uptake of rifampicin (Rif), a traditional antibiotic but not effective against Gram‐negative bacteria. The biomimetic nanodelivery system (Rif@MSN@OMV) is composed of outer membrane vesicles (OMVs) isolated from E. coli as shell and rifampicin‐loaded mesoporous silica nanoparticles (MSNs) as core. The OMVs greatly improve the uptake of MSNs in E. coli, but not in Gram‐positive bacteria S. aureus, owing to the homotypic targeting function of the OMVs. The Rif@MSN@OMV exhibits enhanced antimicrobial activity against E. coli and completely eradicates bacteria at an equivalent rifampicin concentration (4 µg mL−1) while free rifampicin shows weak bactericidal activity. Meanwhile, the Rif@MSN@OMV maintains good biocompatibility both in vitro and in vivo. More importantly, the Rif@MSN@OMV elevates survival rate of infected mice and reduces bacterial load in intraperitoneal fluid and organs. Overall, the OMVs‐coated nanodelivery system provides a novel strategy to improve the antimicrobial efficacy of conventional antibiotic or repurpose drugs for treatment of Gram‐negative bacterial infections.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bacterial Infections and Vaccines · Pneumocystis jirovecii pneumonia detection and treatment · Pneumonia and Respiratory Infections
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences (Shenzhen) Sun Yat‐sen University Shenzhen 518107 China
Institute of Bioengineering and Bioimaging 31 Biopolis Way Singapore 138669 Singapore
Funding
Biomedical Research Council · National Natural Science Foundation of China · Science, Technology and Innovation Commission of Shenzhen Municipality · Fundamental Research Funds for the Central Universities
References (31)
Show source-provided references
1. 10.1126/science.aar377710.1126/science.aar3777 ↗
2. 10.1038/nchembio.175410.1038/nchembio.1754 ↗
3. Lewis R. · FDA Consum. · 1995 · 29 · 11
4. 10.1086/53345210.1086/533452 ↗
5. W. H. O. 2017 Global Priority List of Antibiotic‐Resistant Bacteria to Guide Research Discovery and Development of New Antibiotics http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1(accessed: March 2021).
6. 10.2147/DDDT.S19057710.2147/DDDT.S190577 ↗
7. 10.1039/C9NR09687F10.1039/C9NR09687F ↗
8. 10.1038/s41551-017-0187-510.1038/s41551-017-0187-5 ↗
9. 10.2174/157341305295311010.2174/1573413052953110 ↗
10. 10.3390/vaccines304081410.3390/vaccines3040814 ↗
11. 10.1038/nrmicro142510.1038/nrmicro1425 ↗
12. 10.1038/nature1537310.1038/nature15373 ↗
13. 10.1021/acsami.7b1567810.1021/acsami.7b15678 ↗
14. 10.1038/aps.2017.8210.1038/aps.2017.82 ↗
15. 10.1016/j.jconrel.2020.04.03110.1016/j.jconrel.2020.04.031 ↗
16. 10.1002/adma.20200208510.1002/adma.202002085 ↗
17. 10.1002/pmic.20080027310.1002/pmic.200800273 ↗
18. 10.1038/nrmicro352510.1038/nrmicro3525 ↗
19. 10.1016/j.jconrel.2019.11.01710.1016/j.jconrel.2019.11.017 ↗
20. 10.1016/j.nano.2019.10214810.1016/j.nano.2019.102148 ↗
21. 10.1021/nl504798g10.1021/nl504798g ↗
22. 10.1021/acs.nanolett.9b0218210.1021/acs.nanolett.9b02182 ↗
23. 10.1039/D0TB00472C10.1039/D0TB00472C ↗
24. 10.1016/j.ajps.2019.11.00410.1016/j.ajps.2019.11.004 ↗
25. 10.1016/j.nano.2021.10239810.1016/j.nano.2021.102398 ↗
26. 10.1021/acsinfecdis.8b0021210.1021/acsinfecdis.8b00212 ↗
27. 10.1016/j.ejps.2020.10566510.1016/j.ejps.2020.105665 ↗
28. 10.3109/1061186X.2015.105207410.3109/1061186X.2015.1052074 ↗
29. 10.1002/smll.20170056910.1002/smll.201700569 ↗
30. 10.1039/C2NR32145A10.1039/C2NR32145A ↗
31. 10.1021/acsami.8b1287310.1021/acsami.8b12873 ↗